Indication
Mature B Cell Neoplasms
1 clinical trial
1 product
Product
SHR1459Clinical trial
Phase 1 Study to Evaluate the Tolerance and Pharmacokinetics of SHR1459 in Patients With Recurrentreplased/Refractory Mature B Cell Neoplasms TumorStatus: Active (not recruiting), Estimated PCD: 2023-12-30